Friday, July 24, 2009 9:54:40 PM
MED has a Buy recommendation..
GRT (Earnings Growth Rate): GRT reflects a company's one to three year forecasted earnings growth rate in percent per year. MED has a forecasted Earnings Growth Rate of 28.00%, which VectorVest considers to be excellent.
EPS (Earnings per Share): EPS stands for leading 12 months Earnings Per Share. MED has a forecasted EPS of $0.66 per share.
P/E (Price to Earnings Ratio): P/E is a popular measure of stock valuation which shows the dollars required to buy one dollar of earnings. MED has a P/E of 21.59.
(from Vector Vest July 24, 2009)
Sales: MED has annual sales of $113,000,000.00
Sales Growth: Sales Growth is the Sales Growth Rate in percent over the last 12 months. MED has a Sales Growth of 28.00% per year. This is excellent. Sales Growth is updated each week for every stock. It is often useful to compare Sales Growth to Earnings Growth to gain an insight into a company's operations.
Sales Per Share (SPS): MED has annual sales of $7.92 per share. SPS can be used as a measure of valuation when comparing stocks within an Industry Group.
Price to Sales Ratio (P/S): MED has a P/S of 1.80. This ratio is also used as a measure of valuation. Here, too, it is useful when comparing stocks within an Industry Group.
Shares: MED has 14,000,000.00 shares of stock outstanding.
Market Capitalization: MED has a Market Capitalization of $205,000,000.00. Market Capitalization is calculated by multiplying price times shares outstanding.
Recent MED News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/08/2024 08:58:39 PM
- HSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in Earnings • IH Market News • 04/30/2024 11:55:21 AM
- Medifast Announces First Quarter 2024 Financial Results • Business Wire • 04/29/2024 08:05:00 PM
- Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024 • Business Wire • 04/15/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:24:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 10:23:36 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2024 09:50:57 PM
- Medifast Announces Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/20/2024 09:05:00 PM
- Market Cautiousness Ahead of Retail Giants’ Earnings; Oil Prices Dip • IH Market News • 02/20/2024 10:37:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:52:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:51:12 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 03:36:09 PM
- Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2023 • Business Wire • 02/06/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 12:42:45 PM
- LifeMD and Medifast Partner to Offer Transformative Weight Management Solution • GlobeNewswire Inc. • 12/13/2023 11:00:00 AM
- Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, a Virtual Primary Care Provider, and Adjusting its Capital Allocation Policy • Business Wire • 12/13/2023 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2023 01:20:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2023 01:20:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2023 01:19:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2023 01:19:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2023 01:19:15 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 09:50:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:16:48 PM
- Medifast Announces Third Quarter 2023 Financial Results • Business Wire • 11/06/2023 09:05:00 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM